Modern Care Journal

Published by: Kowsar

The Effects of Lavender, Valerian, and Oxazepam on Anxiety Among Hospitalized Patients with Coronary Artery Disease

Marzie Rafiee 1 , Zahra Kiani 2 , Seyyed Ali Moezi 3 and Gholam Hossein Mahmoudi Rad 4 , *
Authors Information
1 Nursing Education Department, Faculty of Nursing and Midwifery, Birjand University of Medical Sciences, Birjand, IR Iran
2 Cellular and Molecular Research Center, Department of Pharmacology, Birjand University of Medical Sciences, Birjand, IR Iran
3 Atherosclerosis and Coronary Artery Research Center, Birjand University of Medical Sciences, Birjand, IR Iran
4 Faculty of Nursing and Midwifery, Birjand University of Medical Sciences, Birjand, IR Iran
Article information
  • Modern Care Journal: January 2018, 15 (1); e68390
  • Published Online: January 29, 2018
  • Article Type: Research Article
  • Received: November 28, 2017
  • Accepted: January 5, 2018
  • DOI: 10.5812/modernc.68390

To Cite: Rafiee M, Kiani Z, Moezi S A, Mahmoudi Rad G H. The Effects of Lavender, Valerian, and Oxazepam on Anxiety Among Hospitalized Patients with Coronary Artery Disease, Mod Care J. 2018 ;15(1):e68390. doi: 10.5812/modernc.68390.

Abstract
Copyright © 2018, Modern Care Journal. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited
1. Background
2. Methods
3. Results
4. Discussion
Acknowledgements
References
  • 1. Vongpatanasin W. Cardiovascular morbidity and mortality in high-risk populations: epidemiology and opportunities for risk reduction. J Clin Hypertens (Greenwich). 2007;9(11 Suppl 4):11-5. [PubMed: 17978602].
  • 2. World Health Organization. The impact of chronic disease in the islamic republic of Iran. Genouva; 2002.
  • 3. World Health Organization. Mortality country fact sheet 2006. Genouva; 2006.
  • 4. Momeni Ghaleghasemi T, Musarezaie A, Moeini M. Survey of Relationship between spiritual wellbeing with Anxiety and Some Demographic Variables in Patients with Coronary Artery Disease. Res J Health System. 2013;9(7):702-11.
  • 5. Aghajani M, Raisi M, Heidari F. The relationship between Quran and religious believes with death anxiety in heart patients. Supplement of 3th Provincial Congress on Quran and Health. 2013. p. 1-8. Persian.
  • 6. Luttik ML, Jaarsma T, Sanderman R, Fleer J. The advisory brought to practice: routine screening on depression (and anxiety) in coronary heart disease; consequences and implications. Eur J Cardiovasc Nurs. 2011;10(4):228-33. doi: 10.1016/j.ejcnurse.2010.08.005. [PubMed: 20875772].
  • 7. Januzzi JL, Stern TA, Pasternak RC, DeSanctis RW. The Influence of Anxiety and Depression on Outcomes of Patients With Coronary Artery Disease. Arch Intern Med. 2000;160(13):1913. doi: 10.1001/archinte.160.13.1913.
  • 8. Moser DK, Dracup K, Evangelista LS, Zambroski CH, Lennie TA, Chung ML, et al. Comparison of prevalence of symptoms of depression, anxiety, and hostility in elderly patients with heart failure, myocardial infarction, and a coronary artery bypass graft. Heart Lung. 2010;39(5):378-85. doi: 10.1016/j.hrtlng.2009.10.017. [PubMed: 20561849].
  • 9. Denollet J, Brutsaert DL. Personality, disease severity, and the risk of long-term cardiac events in patients with a decreased ejection fraction after myocardial infarction. Circulation. 1998;97(2):167-73. [PubMed: 9445169].
  • 10. Frasure-Smith N, Lesperance F. Depression and anxiety as predictors of 2-year cardiac events in patients with stable coronary artery disease. Arch Gen Psychiatry. 2008;65(1):62-71. doi: 10.1001/archgenpsychiatry.2007.4. [PubMed: 18180430].
  • 11. Memarian R. The effect of Benson relaxation technique on patients' preoperative anxiety in men ward. Daneshvar Sci Res Scholar. 2000;34:8-30. Persian.
  • 12. Snyder L. Complementary and alternative medicine: Ethics, the patient, and the physician. Springer Science & Business Media; 2007.
  • 13. Molassiotis A, Sylt P, Diggins H. The management of cancer-related fatigue after chemotherapy with acupuncture and acupressure: a randomised controlled trial. Complement Ther Med. 2007;15(4):228-37. doi: 10.1016/j.ctim.2006.09.009. [PubMed: 18054724].
  • 14. Richards D. Simple Health Maintenance Based on the Principles of Acupressure and Acupuncture. Sydney: Superior Health Products PTYL; 1991.
  • 15. Alijaniha F, Ghaffari F, Naseri M. Smelling drugs application, in the prevention and treatment of disease, from the perspective of Iranian traditional medicine. History Med J. 2016;5(14):67-77. Persian.
  • 16. Akhondzadeh S, Fallah-Pour H, Afkham K, Jamshidi AH, Khalighi-Cigaroudi F. Comparison of Crocus sativus L. and imipramine in the treatment of mild to moderate depression: a pilot double-blind randomized trial [ISRCTN45683816]. BMC Complement Altern Med. 2004;4:12. doi: 10.1186/1472-6882-4-12. [PubMed: 15341662].
  • 17. Yaghoobi K, Kaka GR, Davoodi S, Ashayeri H. Therapeutic effects of Lavandula angustifolia. J Gorgan Univ Med Sci. 2016;17(4). Persian.
  • 18. Denner SS. Lavandula angustifolia Miller: English lavender. Holist Nurs Pract. 2009;23(1):57-64. doi: 10.1097/01.HNP.0000343210.56710.fc. [PubMed: 19104276].
  • 19. Koulivand PH, Khaleghi Ghadiri M, Gorji A. Lavender and the nervous system. Evid Based Complement Alternat Med. 2013;2013:681304. doi: 10.1155/2013/681304. [PubMed: 23573142].
  • 20. Lee YL, Wu Y, Tsang HW, Leung AY, Cheung WM. A systematic review on the anxiolytic effects of aromatherapy in people with anxiety symptoms. J Altern Complement Med. 2011;17(2):101-8. doi: 10.1089/acm.2009.0277. [PubMed: 21309711].
  • 21. Kasper S, Gastpar M, Muller WE, Volz HP, Moller HJ, Schlafke S, et al. Lavender oil preparation Silexan is effective in generalized anxiety disorder--a randomized, double-blind comparison to placebo and paroxetine. Int J Neuropsychopharmacol. 2014;17(6):859-69. doi: 10.1017/S1461145714000017. [PubMed: 24456909].
  • 22. Shahinfar J, Zera’ati H, Masroornia M, Vafayi S, Hashemi F. Comparison of the effects of lavender and diazepam on the anxiety level of patients before orthopedic surgery. Med Surg Nurs J. 2016;5(3):1-5.
  • 23. Tayebi A, Kasra Dehkordi A, Ebadi A, Sahraei H, Einollahi B. The effect of aromatherapy with lavender essential oil on depression, anxiety and stress in hemodialysis patients: A clinical trial. Evid Based Care. 2015;5(2):65-74. Persian.
  • 24. Khoshkesht S, Bahrami Babahaidari T, Shiri M, Aghabarari M, Hajfiroozabadi M, Jalili HR, et al. The Effect of Aromatherapy on Level of Exam Anxiety Among Nursing Students in Alborz University of Medical Sciences. Alborz Univ Med J. 2015;4(2):101-9. Persian.
  • 25. Houghton PJ. The scientific basis for the reputed activity of Valerian. J Pharm Pharmacol. 1999;51(5):505-12. [PubMed: 10411208].
  • 26. Khazaie F, Modarres M, Rahimikian F, Rahnama P, Bekhradi R, Fallah Huseini H. The effect of lavender essential oil on anxiety of intra uterine device insertion. J Med Plants. 2013;2(46):60-5.
  • 27. Taylor-Piliae RE, Chair SY. The effect of nursing interventions utilizing music therapy or sensory information on Chinese patients' anxiety prior to cardiac catheterization: a pilot study. Eur J Cardiovasc Nurs. 2002;1(3):203-11. Persian. doi: 10.1016/S1474-5151(02)00037-3. [PubMed: 14622675].
  • 28. Kalkhoran MA, Karimollahi M. Religiousness and preoperative anxiety: a correlational study. Ann Gen Psychiatry. 2007;6:17. doi: 10.1186/1744-859X-6-17. [PubMed: 17603897].
  • 29. Nazemian F, Ghafari F, Poorghaznein T. Evaluation of depression and anxiety in hemodialysis patients. Med J Mashhad Univ Med Sci. 2008;51(3):171-6.
  • 30. Woelk H, Schlafke S. A multi-center, double-blind, randomised study of the Lavender oil preparation Silexan in comparison to Lorazepam for generalized anxiety disorder. Phytomedicine. 2010;17(2):94-9. Persian. doi: 10.1016/j.phymed.2009.10.006. [PubMed: 19962288].
  • 31. Rahmati B, Khalili M, Roghani M, Ahghari P. Anti-epileptogenic and antioxidant effect of Lavandula officinalis aerial part extract against pentylenetetrazol-induced kindling in male mice. J Ethnopharmacol. 2013;148(1):152-7. doi: 10.1016/j.jep.2013.04.004. [PubMed: 23603193].
  • 32. Akhondzadeh S, Kashani L, Fotouhi A, Jarvandi S, Mobaseri M, Moin M, et al. Comparison of Lavandula angustifolia Mill. tincture and imipramine in the treatment of mild to moderate depression: a double-blind, randomized trial. Prog Neuropsychopharmacol Biol Psychiatry. 2003;27(1):123-7. [PubMed: 12551734].
  • 33. Nikfarjam M, Parvin N, Asarzadegan N. The effect of Lavandula angustifolia in the treatment of mild to moderate depression. J Shahrekord Univ Med Sci. 2010;11.
  • 34. Abuhamdah S, Chazot PL. Lemon Balm and Lavender herbal essential oils: Old and new ways to treat emotional disorders? Curr Anaesthesia Crit Care. 2008;19(4):221-6. Persian. doi: 10.1016/j.cacc.2008.05.005.
  • 35. Eadie MJ. Could valerian have been the first anticonvulsant? Epilepsia. 2004;45(11):1338-43. Persian. doi: 10.1111/j.0013-9580.2004.27904.x. [PubMed: 15509234].
  • 36. Krystal AD, Ressler I. The use of valerian in neuropsychiatry. CNS Spectr. 2001;6(10):841-7. [PubMed: 15334039].
  • 37. Shabanian G, Rafieian-Kopaei M, Shabanian S, Homaei S, Shabanian M. The comparative effect of Valeriana officinalis versus Diazepam on the state of anxiety before operation in female patients admitted in Kashani hospital. J Clin Nurs Midwifery. 2016;5(1).
  • 38. Ziegler G, Ploch M, Miettinen-Baumann A, Collet W. Efficacy and tolerability of valerian extract LI 156 compared with oxazepam in the treatment of non-organic insomnia--a randomized, double-blind, comparative clinical study. Eur J Med Res. 2002;7(11):480-6. [PubMed: 12568976].
  • 39. Rezaee A, Jafari B, Ahmadizadeh CH, Jalilzadeh M, Ostadi Z, Ebadi AR. Sedation and anxiolytic effect of valerian extract compared with diazepam in rats. J Vet Clin Pathol. 2011;5(1):1051-8. Persian.
  • 40. Yuan CS, Mehendale S, Xiao Y, Aung HH, Xie JT, Ang-Lee MK. The gamma-aminobutyric acidergic effects of valerian and valerenic acid on rat brainstem neuronal activity. Anesth Analg. 2004;98(2):353-8. table of contents. [PubMed: 14742369].
Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:

Author(s):

Article(s):

Create Citiation Alert
via Google Reader

Readers' Comments